Chinese Fund Managers Rush to Capitalize on Investors’ Green Fever (Reuters)
SHANGHAI (Reuters) – Chinese money managers are rushing to launch new energy funds, seeking to capitalize on investors’ green fever which has been fuelled by President Xi Jinping’s carbon neutrality pledge. China’s first photovoltaic industry exchange-traded fund (ETF), launched by Huatai-PineBridge Fund Management Co in December attracted hot demand, with assets under management jumping nearly six-fold in just a month to 10 billion yuan ($1.55 billion).
Survey: Hedge Funds Poised for ’21 Growth (Green Street)
Despite facing a pandemic, historic volatility and billions of dollars in redemptions in 2020, hedge fund professionals are more optimistic about the industry’s future than they have been in years. Hedge Fund Alert’s 13th annual outlook survey asked managers, investors, service providers and other professionals for their takes on topics including asset growth, work-from-home arrangements and the trend toward private equity-style investments. The 55 respondents forecast, on average, that the industry’s total assets would increase by 8.9% in 2021. That’s the rosiest assessment since the survey revealed a 13% growth projection for 2014.
Wednesday 1/6 Insider Buying Report: CODI (Nasdaq.com)
At Compass Diversified, a filing with the SEC revealed that on Monday, D. Eugene Ewing purchased 5,079 shares of CODI, at a cost of $19.61 each, for a total investment of $99,620. So far Ewing is in the green, up about 7.3% on their buy based on today’s trading high of $21.04. Compass Diversified is trading up about 6% on the day Wednesday.
Ultragenyx Pharmaceutical Inc (RARE) President & CEO Emil D Kakkis Sold $4.1 million of Shares (Guru Focus)
President & CEO of Ultragenyx Pharmaceutical Inc, Emil D Kakkis, sold 30,000 shares of RARE on 01/04/2021 at an average price of $136.9 a share. The total sale was $4.1 million. Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.
The President of EnviroLeach Technologies (Other OTC: EVLLF) is Buying Shares (Analyst Ratings)
Today, the President of EnviroLeach Technologies (EVLLF), Duane Anthony Nelson, bought shares of EVLLF for $30K. This recent transaction increases Duane Anthony Nelson’s holding in the company by 5% to a total of $880K. Based on EnviroLeach Technologies’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $573.6K and GAAP net loss of -$1,019,693.
Mets Owner Steve Cohen Subject of Gender Discrimination Complaint (BleacherReport.com)
New York Mets owner Steve Cohen is the subject of a gender discrimination complaint against his hedge fund, Point72 Asset Management, according to the New York Times’ Matthew Goldstein. “In the complaint, Sara Vavra, who led a trading group at Point72, said Mr. Cohen stopped by her office in July 2019 and began ‘an abusive, expletive-ridden tirade’ in which he said her work ‘sucked’ and she was ‘stupid,'” Goldstein reported. “She said in the complaint that beyond dropping a few generic expletives Mr. Cohen also used a derogatory word for a woman’s genitals.”
